Patent · US Active

Beta-arrestin effectors and compositions and methods of use thereof

US9534017B2 · kind B2 · utility

2Cited by
14References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 15, 2014
Grant dateJan 3, 2017
Priority date—
Expiry dateAug 15, 2034

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K7/14
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This application describes a family of compounds acting as β-arrestin effectors. Such compounds may provide significant therapeutic benefit in the treatment of chronic and acute cardiovascular diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.